Influenza virus vaccine

General description Avian Influenza A M2 Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge

Immunogen Antibody was raised against a synthetic peptide corresponding to 16 amino acids in the middle of the avian influenza neuraminidase protein. Efforts were made to use relatively conserved regions as the antigen.

Specificity Influenza A H1 antigen. &#8226: Reacts strongly with the following H1N1 strains: A/Taiwan/1/86, A/USSR/90/77, and all CA strains 1986 to present.

Specificity Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A.

Specificity Specific for the Influenza A nucleoprotein. Has stronger binding with N1-type Flu A.

Specificity Specific for the Influenza A nucleoprotein. Has stronger binding with N2/N3 type Flu A.

Specificity Specific for the influenza A nucleoprotein. Stronger reactivity is observed with N2/N3-type Flu A strains.

Specificity Recognizes Influenza B, anti-core specific: reacts with all strains of Influenza B tested. No reactivity with Flu A or other respiratory viruses.

Influenza virus NS1A-binding protein is a protein encoded by the IVNS1ABP gene in humans. It is a 70kDa protein that interacts with the nonstructural NS1 protein of the influenza A virus.

Anti-IVNS1ABP influenza virus NS1A binding protein, 100ul UN

Anti-IVNS1ABP influenza virus NS1A binding protein, 25ul UN

HOST SPECIES: Rabbit CLONALITY: Polyclonal TESTED APPLICATIONS: E APPLICATIONS: Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 &#956g/ml. SPECIES REACTIVITY: Virus